Nutra Pharma Corp (NPHC) Short-term Investments (2023 - 2026)

Nutra Pharma has disclosed Short-term Investments across 4 years of filings, most recently posting $17600.0 for Q2 2026.

• In Q2 2026, Short-term Investments changed 0.0% year-over-year to $17600.0; the TTM figure through Jun 2026 stood at $17600.0 (changed 0.0% YoY), while the FY2025 annual figure was $17600.0, changed 0.0% from the prior year.
• Short-term Investments came in at $17600.0 for Q2 2026 at Nutra Pharma, roughly flat from $17600.0 in the prior quarter.
• In the past five years, Short-term Investments ranged from a high of $35200.0 in Q4 2023 to a low of $17600.0 in Q1 2024.
• Average Short-term Investments over 4 years is $19200.0, with a median of $17600.0 recorded in 2024.
• Year-over-year, Short-term Investments tumbled 50.0% in 2024 and changed 0.0% in 2025.
• Over 4 years, Short-term Investments stood at $35200.0 in 2023, then plunged by 50.0% to $17600.0 in 2024, then changed by 0.0% to $17600.0 in 2025, then changed by 0.0% to $17600.0 in 2026.
• Per Business Quant data, the three most recent Short-term Investments figures were $17600.0 in Q2 2026, $17600.0 in Q1 2026, and $17600.0 in Q4 2025.